| 000 | 01781 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516004149.0 | ||
| 264 | 0 | _c20110503 | |
| 008 | 201105s 0 0 eng d | ||
| 022 | _a1873-5010 | ||
| 024 | 7 |
_a10.1016/j.jcf.2010.09.003 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAdeboyeku, D | |
| 245 | 0 | 0 |
_aTwice vs three-times daily antibiotics in the treatment of pulmonary exacerbations of cystic fibrosis. _h[electronic resource] |
| 260 |
_bJournal of cystic fibrosis : official journal of the European Cystic Fibrosis Society _cJan 2011 |
||
| 300 |
_a25-30 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCeftazidime _xadministration & dosage |
| 650 | 0 | 4 |
_aCystic Fibrosis _xcomplications |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Monitoring |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aEar Diseases _xchemically induced |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 |
_aKidney Diseases _xchemically induced |
| 650 | 0 | 4 |
_aLung _xmicrobiology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPseudomonas Infections _xdrug therapy |
| 650 | 0 | 4 |
_aPseudomonas aeruginosa _xdrug effects |
| 650 | 0 | 4 | _aRespiratory Function Tests |
| 650 | 0 | 4 |
_aTobramycin _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aJones, A L | |
| 700 | 1 | _aHodson, M E | |
| 773 | 0 |
_tJournal of cystic fibrosis : official journal of the European Cystic Fibrosis Society _gvol. 10 _gno. 1 _gp. 25-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jcf.2010.09.003 _zAvailable from publisher's website |
| 999 |
_c20226900 _d20226900 |
||